Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: Correlation with G-banding analysis and FISH

Experimental Hematology

Volumn 41, Issue 2, 2013, Pages 198-208

  de Oliveira, Fábio Morato ^a,b   Lucena Araujo, Antonio Roberto ^a,b   Favarin, Maria do Carmo ^a   Bonini Palma, Patrícia Vianna ^b   Rego, Eduardo Magalhães ^a,b   Falcão, Roberto Passetto ^a,b   Covas, Dimas Tadeu ^a,b   Fontes, Aparecida Maria ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b National Institute of Science and Technology in Stem Cell and Cell Therapy   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; AURORA B KINASE;

5Q- SYNDROME; ADULT; AGED; ANEUPLOIDY; ARTICLE; AURKA GENE; AURKB GENE; BONE MARROW CELL; CELL EXPANSION; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; G BANDING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANEUPLOIDY; BONE MARROW CELLS; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; ENZYME INDUCTION; FEMALE; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPE; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; STEM CELL NICHE;

EID: 84873515758     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.10.009     Document Type: Article

References (35)

1. Bernasconi P. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review. Br J Haematol 2008, 142:695-708.
2. Knudson A. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971, 68:820-823.
3. Bejar R., Levine R., Ebert B.L. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J Clin Oncol 2011, 29:504-515.
4. Podar K., Richardson P.G., Hideshima T., Chauhan D., Anderson K.C. The malignant clone and the bone-marrow environment. Best Pract Res Clin Haematol 2007, 20:597-612.
5. Nimer S.D. MDS: a stem cell disorder-but what exactly is wrong with the primitive hematopoietic cells in this disease?. Hematology Am Soc Hematol Educ Program 2008, 43-51.
6. Raaijmakers M.H. Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis. Int J Hematol 2012, 95:17-25.
7. Friedenstein A.J. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974, 2:83-92.
8. Meirelles Lda S., Fontes A.M., Covas D.T., Caplan A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009, 20:419-427.
9. Flores-Figueroa E., Montesinos J.J., Flores-Guzmán P., et al. Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells. Leuk Res 2008, 32:1407-1416.
10. Konopleva M., Konoplev S., Hu W., Zaritskey A.Y., Afanasiev B.V., Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 2002, 16:1713-1724.
11. Raaijmakers M.H., Mukherjee S., Guo S., et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010, 464:852-857.
12. Blau O., Hofmann W.K., Baldus C.D., et al. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia. Exp Hematol 2007, 35:221-229.
13. Flores-Figueroa E., Arana-Trejo R.M., Gutiérrez-Espíndola G., Pérez-Cabrera A., Mayani H. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Leuk Res 2005, 29:215-224.
14. Lopez-Villar O., Garcia J.L., Sanchez-Guijo F.M., et al. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome. Leukemia 2009, 23:664-672.
15. Klaus M., Stavroulaki E., Kastrinaki M.C., et al. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes. Stem Cells Dev 2010, 19:1043-1054.
16. Nigg E.A. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001, 2:21-32.
17. Jeng Y.M., Peng S.Y., Lin C.Y., Hsu H.C. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004, 10:2065-2071.
18. Kamada K., Yamada Y., Hirao T., et al. Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis. Oncol Rep 2004, 12:593-599.
19. Tanaka E., Hashimoto Y., Ito T., et al. The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005, 11:1827-1834.
20. Sen S., Zhou H., White R.A. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 1997, 14:2195-2200.
21. Lucena-Araujo A.R., de Oliveira F.M., Leite-Cueva S.D., dos Santos G.A., Falcao R.P., Rego E.M. High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia. Leuk Res 2011, 35:260-264.
22. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002, 100:2292-2302.
23. Covas D.T., Siufi J.L., Silva A.R., Orellana M.D. Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res 2003, 36:1179-1183.
24. Stenderup K., Justesen J., Clausen C., Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926.
25. ISCN 2009: an international system for human cytogenetic nomenclature 2009 2009, S. Karger, Basel. L.G. Shaffer, M.L. Slovak, L.J. Campbell (Eds.).
26. Roela R.A., Carraro D.M., Brentani H.P., et al. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes. Leuk Res 2007, 31:579-589.
27. Vader G., Lens S.M. The Aurora kinase family in cell division and cancer. Biochim Biophys Acta 2008, 1786:60-72.
28. Meraldi P., Honda R., Nigg E.A. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 2004, 14:29-36.
29. Bischoff J.R., Anderson L., Zhu Y., et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998, 17:3052-3065.
30. Zhou H., Kuang J., Zhong L., et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998, 20:189-193.
31. Meraldi P., Honda R., Nigg E.A. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 2002, 21:483-492.
32. Tatsuka M., Sato S., Kitajima S., et al. Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis. Oncogene 2005, 24:1122-1127.
33. Torres E.M., Sokolsky T., Tucker C.M., et al. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 2007, 317:916-924.
34. Segal D.J., McCoy E.E. Studies on Down's syndrome in tissue culture. I. Growth rates and protein contents of fibroblast cultures. J Cell Physiol 1974, 83:85-90.
35. Li D., Zhu J., Firozi P.F., et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003, 9:991-997.